Cell Membrane–Liposome Hybrid Platform for Ultrasound-Activated Immune-Sonodynamic Therapy for Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

Cell Membrane–Liposome Hybrid Platform for Ultrasound-Activated Immune-Sonodynamic Therapy for Triple-Negative Breast Cancer

Published:2023-09-08 Issue:18 Volume:6 Page:16453-16464
ISSN:2574-0970
Container-title:ACS Applied Nano Materials
language:en
Short-container-title:ACS Appl. Nano Mater.

Author:

Wang Haiping¹²,Yang Fang³,Li Yixiang³,Zhang Song⁴,Shang Jinting¹²,Hou Xiaoying¹²,Tong Yumeng¹,Zhou Kangying¹,Shu Xiji¹,Sun Binlian¹²,Lu Chunhua⁵^ORCID,Liu Yuchen¹²

Affiliation:

1. Wuhan Institute of Biomedical Sciences, School of Medicine, Jianghan University, Wuhan 430056, Hubei, China

2. Cancer Institute, School of Medicine, Jianghan University, Wuhan 430056, Hubei, China

3. Medical College of Guangxi University, Nanning 530004, Guangxi, China

4. Department of Gastroenterology, General Hospital of Central Theater Command, Wuhan 430070, Hubei, China

5. Medical Experimental Center, The First People’s Hospital of Nanning, Nanning 530021, Guangxi, China

Funder

Health Commission of Hubei Province

Jianghan University

Natural Science Foundation of Guangxi Province

Natural Science Foundation of Hubei Province

National Natural Science Foundation of China

Youth Foundation of General Hospital of Central Theater Command

Publisher

American Chemical Society (ACS)

Subject

General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/acsanm.3c02687

Reference33 articles.

1. Targeted Therapies for Triple-Negative Breast Cancer

2. Triple-negative breast cancer treatment in xenograft models by bifunctional nanoprobes combined to photodynamic therapy

3. Mechanism-Based Sonodynamic–Chemo Combinations against Triple-Negative Breast Cancer

4. Boosting immunotherapy of triple negative breast cancer through the synergy of mild PTT and Fe-loaded organosilica nanoparticles

5. Recent trends of mesoporous silica-based nanoplatforms for nanodynamic therapies

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regorafenib enhances the efficacy of photodynamic therapy in hepatocellular carcinoma through MAPK signaling pathway suppression;Photodiagnosis and Photodynamic Therapy;2024-10